JP2014504146A5 - - Google Patents
Download PDFInfo
- Publication number
- JP2014504146A5 JP2014504146A5 JP2013518619A JP2013518619A JP2014504146A5 JP 2014504146 A5 JP2014504146 A5 JP 2014504146A5 JP 2013518619 A JP2013518619 A JP 2013518619A JP 2013518619 A JP2013518619 A JP 2013518619A JP 2014504146 A5 JP2014504146 A5 JP 2014504146A5
- Authority
- JP
- Japan
- Prior art keywords
- peptide
- group
- complex
- apc
- hla antigen
- Prior art date
- Legal status (The legal status is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the status listed.)
- Withdrawn
Links
- 108090000765 processed proteins & peptides Proteins 0.000 claims 35
- 239000000427 antigen Substances 0.000 claims 11
- 102000036639 antigens Human genes 0.000 claims 11
- 108091007433 antigens Proteins 0.000 claims 11
- 210000001151 cytotoxic T lymphocyte Anatomy 0.000 claims 11
- 150000001413 amino acids Chemical group 0.000 claims 10
- 239000002157 polynucleotide Substances 0.000 claims 9
- 102000040430 polynucleotide Human genes 0.000 claims 9
- 108091033319 polynucleotide Proteins 0.000 claims 9
- 210000001744 T-lymphocyte Anatomy 0.000 claims 8
- 230000001939 inductive effect Effects 0.000 claims 7
- 229940024606 amino acid Drugs 0.000 claims 6
- 102000004196 processed proteins & peptides Human genes 0.000 claims 6
- 239000000203 mixture Substances 0.000 claims 5
- 206010028980 Neoplasm Diseases 0.000 claims 4
- 201000011510 cancer Diseases 0.000 claims 4
- 210000004027 cell Anatomy 0.000 claims 4
- 238000012258 culturing Methods 0.000 claims 4
- 210000001808 exosome Anatomy 0.000 claims 4
- 239000012634 fragment Substances 0.000 claims 4
- 238000000338 in vitro Methods 0.000 claims 4
- 238000000034 method Methods 0.000 claims 4
- 210000000612 antigen-presenting cell Anatomy 0.000 claims 3
- 229920001184 polypeptide Polymers 0.000 claims 3
- FFEARJCKVFRZRR-BYPYZUCNSA-N L-methionine Chemical compound CSCC[C@H](N)C(O)=O FFEARJCKVFRZRR-BYPYZUCNSA-N 0.000 claims 2
- COLNVLDHVKWLRT-QMMMGPOBSA-N L-phenylalanine Chemical compound OC(=O)[C@@H](N)CC1=CC=CC=C1 COLNVLDHVKWLRT-QMMMGPOBSA-N 0.000 claims 2
- QIVBCDIJIAJPQS-VIFPVBQESA-N L-tryptophane Chemical compound C1=CC=C2C(C[C@H](N)C(O)=O)=CNC2=C1 QIVBCDIJIAJPQS-VIFPVBQESA-N 0.000 claims 2
- QIVBCDIJIAJPQS-UHFFFAOYSA-N Tryptophan Natural products C1=CC=C2C(CC(N)C(O)=O)=CNC2=C1 QIVBCDIJIAJPQS-UHFFFAOYSA-N 0.000 claims 2
- 229930182817 methionine Natural products 0.000 claims 2
- 239000002773 nucleotide Substances 0.000 claims 2
- 125000003729 nucleotide group Chemical group 0.000 claims 2
- 239000008194 pharmaceutical composition Substances 0.000 claims 2
- COLNVLDHVKWLRT-UHFFFAOYSA-N phenylalanine Natural products OC(=O)C(N)CC1=CC=CC=C1 COLNVLDHVKWLRT-UHFFFAOYSA-N 0.000 claims 2
- 230000002265 prevention Effects 0.000 claims 2
- 125000001433 C-terminal amino-acid group Chemical group 0.000 claims 1
- 238000009007 Diagnostic Kit Methods 0.000 claims 1
- 108010013476 HLA-A24 Antigen Proteins 0.000 claims 1
- AGPKZVBTJJNPAG-WHFBIAKZSA-N L-isoleucine Chemical compound CC[C@H](C)[C@H](N)C(O)=O AGPKZVBTJJNPAG-WHFBIAKZSA-N 0.000 claims 1
- ROHFNLRQFUQHCH-YFKPBYRVSA-N L-leucine Chemical compound CC(C)C[C@H](N)C(O)=O ROHFNLRQFUQHCH-YFKPBYRVSA-N 0.000 claims 1
- OUYCCCASQSFEME-QMMMGPOBSA-N L-tyrosine Chemical compound OC(=O)[C@@H](N)CC1=CC=C(O)C=C1 OUYCCCASQSFEME-QMMMGPOBSA-N 0.000 claims 1
- ROHFNLRQFUQHCH-UHFFFAOYSA-N Leucine Natural products CC(C)CC(N)C(O)=O ROHFNLRQFUQHCH-UHFFFAOYSA-N 0.000 claims 1
- 239000003937 drug carrier Substances 0.000 claims 1
- 230000028993 immune response Effects 0.000 claims 1
- 229960000310 isoleucine Drugs 0.000 claims 1
- AGPKZVBTJJNPAG-UHFFFAOYSA-N isoleucine Natural products CCC(C)C(N)C(O)=O AGPKZVBTJJNPAG-UHFFFAOYSA-N 0.000 claims 1
- 108091005601 modified peptides Proteins 0.000 claims 1
- 238000006467 substitution reaction Methods 0.000 claims 1
- 238000001356 surgical procedure Methods 0.000 claims 1
- OUYCCCASQSFEME-UHFFFAOYSA-N tyrosine Natural products OC(=O)C(N)CC1=CC=C(O)C=C1 OUYCCCASQSFEME-UHFFFAOYSA-N 0.000 claims 1
Applications Claiming Priority (3)
| Application Number | Priority Date | Filing Date | Title |
|---|---|---|---|
| US40551710P | 2010-10-21 | 2010-10-21 | |
| US61/405,517 | 2010-10-21 | ||
| PCT/JP2011/005866 WO2012053206A1 (en) | 2010-10-21 | 2011-10-20 | Wdhd1 peptides and vaccines including the same |
Publications (2)
| Publication Number | Publication Date |
|---|---|
| JP2014504146A JP2014504146A (ja) | 2014-02-20 |
| JP2014504146A5 true JP2014504146A5 (enExample) | 2014-11-27 |
Family
ID=45974936
Family Applications (1)
| Application Number | Title | Priority Date | Filing Date |
|---|---|---|---|
| JP2013518619A Withdrawn JP2014504146A (ja) | 2010-10-21 | 2011-10-20 | Ｗｄｈｄ１ペプチドおよびそれを含むワクチン |
Country Status (14)
| Country | Link |
|---|---|
| US (1) | US9056890B2 (enExample) |
| EP (1) | EP2630238A4 (enExample) |
| JP (1) | JP2014504146A (enExample) |
| KR (1) | KR20130138804A (enExample) |
| CN (1) | CN103270156B (enExample) |
| AU (1) | AU2011319359A1 (enExample) |
| BR (1) | BR112013009526A2 (enExample) |
| CA (1) | CA2815102A1 (enExample) |
| IL (1) | IL225552A0 (enExample) |
| MX (1) | MX2013004417A (enExample) |
| RU (1) | RU2013123045A (enExample) |
| SG (1) | SG189222A1 (enExample) |
| TW (1) | TW201216982A (enExample) |
| WO (1) | WO2012053206A1 (enExample) |
Families Citing this family (2)
| Publication number | Priority date | Publication date | Assignee | Title |
|---|---|---|---|---|
| AU2013317194B2 (en) | 2012-09-11 | 2018-07-12 | Oncotherapy Science, Inc. | UBE2T peptides and vaccines containing the same |
| MX2019008878A (es) | 2017-01-25 | 2020-02-13 | Ose Immunotherapeutics | Metodo para fabricar una emulsion estable para suministro de peptidos. |
Family Cites Families (4)
| Publication number | Priority date | Publication date | Assignee | Title |
|---|---|---|---|---|
| WO2004018667A1 (ja) * | 2002-08-26 | 2004-03-04 | Kirin Beer Kabushiki Kaisha | ペプチド及びこれを含む医薬 |
| JP2008540340A (ja) | 2005-04-28 | 2008-11-20 | マクギル ユニバーシティー | カドヘリン介在過程を調節する化合物及び方法 |
| EP2190985A4 (en) | 2007-08-24 | 2010-12-15 | Oncotherapy Science Inc | GENES RELATED TO CANCER, CDCA5, EPHA7, STK31 AND WDHD1 |
| US20100159513A1 (en) | 2008-12-20 | 2010-06-24 | E. I. Du Pont De Nemours And Compnay | Genes that increase peptide production |
-
2011
- 2011-10-19 TW TW100137833A patent/TW201216982A/zh unknown
- 2011-10-20 CN CN201180060624.7A patent/CN103270156B/zh not_active Expired - Fee Related
- 2011-10-20 US US13/880,442 patent/US9056890B2/en not_active Expired - Fee Related
- 2011-10-20 RU RU2013123045/10A patent/RU2013123045A/ru not_active Application Discontinuation
- 2011-10-20 BR BR112013009526A patent/BR112013009526A2/pt not_active IP Right Cessation
- 2011-10-20 KR KR1020137012792A patent/KR20130138804A/ko not_active Withdrawn
- 2011-10-20 SG SG2013024427A patent/SG189222A1/en unknown
- 2011-10-20 EP EP11834052.0A patent/EP2630238A4/en not_active Withdrawn
- 2011-10-20 WO PCT/JP2011/005866 patent/WO2012053206A1/en not_active Ceased
- 2011-10-20 MX MX2013004417A patent/MX2013004417A/es not_active Application Discontinuation
- 2011-10-20 JP JP2013518619A patent/JP2014504146A/ja not_active Withdrawn
- 2011-10-20 CA CA2815102A patent/CA2815102A1/en not_active Abandoned
- 2011-10-20 AU AU2011319359A patent/AU2011319359A1/en not_active Abandoned
-
2013
- 2013-04-04 IL IL225552A patent/IL225552A0/en unknown